Description
Bevnexxa 100mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient, bevacizumab, is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF). By blocking VEGF, Bevnexxa helps to reduce the blood supply to tumors, thereby slowing or stopping their growth. It is commonly used in combination with chemotherapy for metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma. Bevnexxa 100mg Injection is administered intravenously by a healthcare professional. Patients should inform their doctor about any pre-existing medical conditions, especially heart disease, high blood pressure, or a history of bleeding disorders, as these can affect treatment. Potential side effects include hypertension, proteinuria, and delayed wound healing. Store the injection at room temperature and protect it from light. Do not freeze.
